Skip to main content
NIH funding notice RFA-DA-25-005

Research on the Neuro-Immune Axis in the Context of HIV and Substance Use (R21 Clinical Trial Not Allowed)

Closed on November 13, 2024.

Posted
March 14, 2024
Close date
November 13, 2024
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $439,180 in first-year total cost, median $439,180.

Most frequent study sections

  1. Special Emphasis Panel[ZDA1 PXN-N (M1)]1

Most frequent institutions

  1. JOHNS HOPKINS UNIVERSITY1
Competing awards under RFA-DA-25-005 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2025Deconvoluting Dopaminergic Neuronal-Glial Interactions in the Striatum1R21DA064062-01BROWN, AMANDA MARIALEE, PILHWAJOHNS HOPKINS UNIVERSITY, MD$439,180ZDA1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.